Drug Profile
ADV 6208
Alternative Names: ADV6208Latest Information Update: 28 Oct 2018
Price :
$50
*
At a glance
- Originator Advicenne
- Class Antiepileptic drugs; Neuropsychotherapeutics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Seizures
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for phase-I development in Seizures(In adolescents, In children, In infants) in France
- 30 Sep 2015 Phase-I clinical trials in Seizures (In infants, In children, In adolescents) in France (unspecified route) before September 2015